| Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA‐Ar) JT Sullivan, K Sykora, J Schneiderman, CA Naranjo, EM Sellers British journal of addiction 84 (11), 1353-1357, 1989 | 2251 | 1989 |
| Pharmacological Management of Alcohol Withdrawal. A Meta-analysis and Evidence-Based Practice Guideline. CSJTJTS Mayo-Smith M F, for the American Society of Addiction Medicine ... JAMA 278 (2), 144-151, 1997 | 1023 | 1997 |
| The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective TD Bjornsson, JT Callaghan, HJ Einolf, V Fischer, L Gan, S Grimm, J Kao, ... Drug metabolism and disposition 31 (7), 815-832, 2003 | 927 | 2003 |
| Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand B Wang, JL Nichol, JT Sullivan Clinical Pharmacology & Therapeutics 76 (6), 628-638, 2004 | 354 | 2004 |
| The conduct of in vitro and in vivo drug‐drug interaction studies: a PhRMA perspective TD Bjornsson, JT Callaghan, HJ Einolf, V Fischer, L Gan, S Grimm, J Kao, ... The Journal of Clinical Pharmacology 43 (5), 443-469, 2003 | 349 | 2003 |
| The serotonin uptake inhibitor citalopram attenuates ethanol intake CA Naranjo, EM Sellers, JT Sullivan, DV Woodley, K Kadlec, K Sykora Clinical Pharmacology & Therapeutics 41 (3), 266-274, 1987 | 329 | 1987 |
| Effects of a novel glucagon receptor antagonist (Bay 27–9955) on glucagon-stimulated glucose production in humans KF Petersen, JT Sullivan Diabetologia 44, 2018-2024, 2001 | 248 | 2001 |
| Pharmacokinetics of a once-daily oral dose of moxifloxacin (Bay 12-8039), a new enantiomerically pure 8-methoxy quinolone JT Sullivan, M Woodruff, J Lettieri, V Agarwal, GJ Krol, PT Leese, ... Antimicrobial agents and Chemotherapy 43 (11), 2793-2797, 1999 | 150 | 1999 |
| Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. SL Walsh, JT Sullivan, KL Preston, JE Garner, GE Bigelow Journal of Pharmacology and Experimental Therapeutics 279 (2), 524-538, 1996 | 149 | 1996 |
| Pharmacokinetics of anakinra in subjects with different levels of renal function BB Yang, S Baughman, JT Sullivan Clinical Pharmacology & Therapeutics 74 (1), 85-94, 2003 | 146 | 2003 |
| Fluoxetine alters the effects of intravenous cocaine in humans SL Walsh, KL Preston, JT Sullivan, R Fromme, GE Bigelow Journal of clinical psychopharmacology 14 (6), 396-407, 1994 | 136 | 1994 |
| Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using a standardized withdrawal scale JT Sullivan, RM Swift, DC Lewis Journal of clinical psychopharmacology 11 (5), 291-295, 1991 | 116 | 1991 |
| Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. KL Preston, JT Sullivan, EC Strain, GE Bigelow Journal of Pharmacology and Experimental Therapeutics 262 (1), 279-291, 1992 | 109 | 1992 |
| Differential effects of viqualine on alcohol intake and other consummatory behaviors CA Naranjo, JT Sullivan, KE Kadlec, DV Woodley‐Remus, G Kennedy, ... Clinical Pharmacology & Therapeutics 46 (3), 301-308, 1989 | 108 | 1989 |
| Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. KL Preston, JT Sullivan, EC Strain, GE Bigelow Journal of Pharmacology and Experimental Therapeutics 262 (1), 279-291, 1992 | 103 | 1992 |
| Effects of cocaine alone and in combination with mazindol in human cocaine abusers. KL Preston, JT Sullivan, P Berger, GE Bigelow Journal of Pharmacology and Experimental Therapeutics 267 (1), 296-307, 1993 | 90 | 1993 |
| Prevalence of hepatitis C in a chemically dependent population MI Fingerhood, DR Jasinski, JT Sullivan Archives of internal medicine 153 (17), 2025-2030, 1993 | 90 | 1993 |
| Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily RZ Harris, D Padhi, TC Marbury, RJ Noveck, M Salfi, JT Sullivan American journal of kidney diseases 44 (6), 1070-1076, 2004 | 81 | 2004 |
| Absolute bioavailability of moxifloxacin C Ballow, J Lettieri, V Agarwal, P Liu, H Stass, JT Sullivan Clinical therapeutics 21 (3), 513-522, 1999 | 77 | 1999 |
| Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation JGF Cleland, JT Sullivan, S Ball, JD Horowitz, B Agoram, D Rosser, ... Journal of cardiovascular pharmacology 46 (2), 155-161, 2005 | 70 | 2005 |
Edward M SellersUniversity of TorontoVerified email at dlglobalpartners.com
